Loblaw Companies Ltd
OTC:LBLCF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Loblaw Companies Ltd
OTC:LBLCF
|
CA |
|
Relmada Therapeutics Inc
NASDAQ:RLMD
|
US |
|
O
|
Overstock.com Inc
F:OVER
|
US |
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
US |
|
Airbus SE
PAR:AIR
|
NL |
|
Newtek Business Services Corp
NASDAQ:NEWT
|
US |
|
Danaos Corp
NYSE:DAC
|
GR |
|
A
|
Allianz SE
F:ALV
|
DE |
|
Cass Information Systems Inc
NASDAQ:CASS
|
US |
|
M
|
Marks and Spencer Group PLC
OTC:MAKSF
|
UK |
|
Driven Brands Holdings Inc
NASDAQ:DRVN
|
US |
|
B
|
Brunswick Corp
F:BWI
|
US |
|
Ubiquiti Inc
NYSE:UI
|
US |
Wall St Price Targets
LBLCF Price Targets Summary
Loblaw Companies Ltd
According to Wall Street analysts, the average 1-year price target for LBLCF is 49.1492 USD with a low forecast of 44.6234 USD and a high forecast of 54.364 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LBLCF's stock price target?
Price Target
49.1492
USD
According to Wall Street analysts, the average 1-year price target for LBLCF is 49.1492 USD with a low forecast of 44.6234 USD and a high forecast of 54.364 USD.
What is the Revenue forecast for Loblaw Companies Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for Loblaw Companies Ltd?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Loblaw Companies Ltd?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 6%.
